PharmaRadar360

PharmaRadar360

πŸ‡¨πŸ‡¦Β·Aug 31Regulatory

JAMP Temozolomide: Out-of-Specification (Assay)

The active ingredient (temozolomide) is out of specification in the affected lot.

Publisher

H
Health Canada Recalls and Safety Alerts

Canada

This page provides a limited summary, publisher metadata, and related coverage to support discovery before sending readers to the original article.

Read original

At a glance

Publisher
Health Canada Recalls and Safety Alerts
Region
Canada
Scope
Regulatory
Published
August 31, 2026
Language
EN

Topics

OGL-Canada-2.0

Publisher context, original article off-platform

This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.

Summary excerpt

The active ingredient (temozolomide) is out of specification in the affected lot.

Source route

Continue on recalls-rappels.canada.ca

Leave the platform to read the original full article on the publisher site.

Source: Health Canada Recalls and Safety Alerts

Scope: Regulatory

Open original article
JAMP Temozolomide: Out-of-Specification (Assay) | PharmaRadar360